Clinical Trial Update: Study Evaluating Etanercept in Moderate to Severe Asthma [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating etanercept for moderate to severe asthma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Etanercept (etanercept)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Asthma | Phase 2 | Status: COMPLETED